Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.
Pharmaceutical Executive: What elements is the conversation about bringing pharma manufacturing home missing? Charlie Lyon: ...
GlobalData on MSN
Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing
When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.
Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...
Eighty-six percent of manufacturing leaders believe the technologies they adopt today will be the main driver of competitiveness in the next five years. Yet, for many manufacturing leaders, navigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results